Monitoring and Preventing Equine Herpesvirus Abortions
The monitoring of abortions attributable to equine herpesvirus-1 (EHV-1) initiated in 1957 among the Thoroughbred mare population of Central Kentucky has continued annually for the past 51 years. The number of EHV-1 abortions per 1,000 pregnant mares has remained below five since 1977 despite a doubling in size of the mare population (as illustrated in Figure 2 below). This number is based on accessions to the University of Kentucky Livestock Disease Diagnostic Center (LDDC) and confirmed by laboratory diagnosis, and it is considered an accurate reflection of the field incidence. This accurate number is due to the diligence of farm managers and attending veterinarians ensuring that all fetuses and neonatal foal losses are submitted for examination.
Prevention of EHV-1 Abortion
- Divide pregnant mares into groups by stage of gestation and maintain in isolation.
- Isolate all new arrivals for 21 days.
- Keep first foaling mares away from other mares.
- If mares are removed, do no re-introduce.
- Segregate pregnant mares from weanlings and other horses.
- Keep foster mares away from other mares.
- Maintain vaccination program.
The number of EHV-1 abortions per 1,000 pregnant mares has remained below five since 1977 despite a doubling in size of the mare population. Since 1977 the overall number of EHV-1 abortions has ranged from a low of 11 in 1993 to a high of 47 in 1997, with 18 recorded in 2006 and 22 in 2007. The majority of cases in recent years are single events on individual farms among a population of mares that is routinely vaccinated against the disease. However, multiple abortions may still occur, as evidenced by one farm in 2007 that experienced six abortions.
Action to be Taken if an Abortion Occurs
- Place aborted fetus and membranes in leak-proof container and dispatch to diagnostic laboratory.
- Disinfect and clean contaminated area.
- Place mare in isolation.
- Do not move in-contact mares.
- If positive for EHV-1 split in-contact mares into smaller groups.
Contact:
Dr. David G. Powell, 859/257-4757; Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky; Lexington, KY
or
Dr. Mary Lynne Vickers, 859/253-0571; Livestock Disease Diagnostic Center, University of Kentucky; Lexington, KY
This is an excerpt from Equine Disease Quarterly, funded by underwriters at Lloyd’s, London, brokers, and their Kentucky agents.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com. Already have an account?Create a free account with TheHorse.com to view this content.
Start your free account today!
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with